HAART use in women with HIV and influence on cervical intraepithelial neoplasia: A clinical opinion

Journal of Lower Genital Tract Disease

Volumn 6, Issue 2, 2002, Pages 111-115

  Khanna, Niharika ^a  

^a NONE   (United States)

Author keywords

Cervical intraepithelial neoplasia; Highly active antiretroviral therapy; HIV; Immunocompetence

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; CD4 ANTIGEN;

CANCER RISK; CONDYLOMA; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; DRUG USE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOCOMPETENCE; INFECTION PREVENTION; LYMPHOCYTE COUNT; MEDICAL LITERATURE; NONHUMAN; POPULATION RESEARCH; RECURRENT VIRUS INFECTION; REVIEW; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; VIRUS LOAD; WART VIRUS;

EID: 0036265498     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/00128360-200204000-00007     Document Type: Review

References (46)

1. Is infection with HIV a risk for cervical intraepithelial neoplasia?
2. Increased frequency of cervical dysplasia/neoplasia in HIV-infected women is related to the extent of immunodepression
3. Re: Cervical carcinoma and human papillomavirus: On the road to preventing a major human cancer
4. Old and new issues in cervical cancer control
5. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults
6. Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus
7. Human papillomavirus and the risk of cervical cancer
8. Cervico-vaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV) positive and high risk HIV negative women
9. The significance of ASCUS cytology in HIV-positive women
10. The impact of the human immunodeficiency virus on the human papillomavirus epidemic
11. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus
12. Papanicolaou smears in human immunodeficiency virus-seropositive women during follow-up
13. The value of cervical cytology in HIV-infected women
14. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions
15. Comparative prevalence, incidence, and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women
16. Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women
17. Cervical dysplasia in HIV-seropositive women: Role of human papillomavirus infection and immune status
18. Prevalence of and risk for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: Impact of infection with human immunodeficiency virus
19. Comparison of PCR and hybrid capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection
20. Incidence of cervical squamous intraepithelial lesions in HIV-infected women
21. Papillomavirus
22. Characterization of soluble factors from cultures of premalignant cervical epithelium
23. Analysis of cytokine profiles in patients with human papillomavirus-associated neoplasms
24. Cytokine production patterns in cervical intraepithelial neoplasia: Association with human papillomavirus infection
25. Th1 cytokine patterns in cervical human papillomavirus infection
26. HPV 16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes
27. The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha
28. Role of human immunodeficiency virus infection in the pathogenesis of human papillomavirus - Associated cervical neoplasia
29. Cellular immunodeficiency enhances the progression of human papillomavirus - Associated cervical lesions
30. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load
31. Cervical cancer as an AIDS-defining illness
32. Evolution of cervical abnormalities among women with HIV-1: Evidence from surveillance cytology in the Women's Health Interagency HIV study
33. Human papillomavirus in women infected with the human immunodeficiency virus
34. AIDS-related cancers in the era of highly active antiretroviral therapy
35. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy
36. Update: Cancer risk in persons with HIV/AIDS in the era of combination antiretroviral therapy
37. The effect of highly active antiretroviral therapy on cervical changes associated with oncogenic HPV among HIV -infected women
38. Different pattern of AIDS-defining diseases in persons responding to highly active antiretroviral therapy
39. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy
40. Role of highly active antiretroviral therapy in human papillomavirus-induced genital dysplasia in HIV-1-infected patients
41. Cervical intraepithelial neoplasia in human immunodeficiency virus-positive patients
42. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus
43. Effect of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immunodeficiency virus
44. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: Effect of highly active antiretroviral therapy
45. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma
46. Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women